OAM
ANIP icon

OP Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

OP Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,733
Closed -$113K – 790
2025
Q2 		$113K Sell
1,733
-5,817
-77% -$379K ﹤0.01% 755
2025
Q1 		$505K Buy
+7,550
New +$451K 0.01% 668

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OP Asset Management's ANIP Position: Q3 2025 in Review

OP Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q3 2025, closing a stake of 1,733 shares — an estimated $113K sold.

OP Asset Management first reported a position in ANIP in Q1 2025 and held it in 2 quarters. The position peaked at $505K in Q1 2025. 269 funds tracked by Wall St. Rank hold ANIP as of Q3 2025.

  • OP Asset Management reported no remaining ANI Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • OP Asset Management sold 1,733 ANI Pharmaceuticals shares in Q3 2025, an estimated $113K.
  • OP Asset Management first reported a position in ANI Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • OP Asset Management's ANI Pharmaceuticals position peaked at $505K in Q1 2025.
  • 269 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2025.

Based on OP Asset Management's 13F filing for Q3 2025, filed 20 Apr 2026.